Table 2.
Capture of CTCs from metastatic and non-metastatic syngeneic mouse models of lung cancer
| Group | Sample | End tumor volume (mm3) | Collected blood volume (μL) | Captured CTCs (CTCs/100 μL) |
|---|---|---|---|---|
| Metastasis-Prone (344SQ) | #1 | 179 | 500 | 84 |
| #2 | 144 | 500 | 28 | |
| #3 | 1470 | 350 | 336 | |
| #4 | 503.5 | 500 | 84 | |
| #5 | 988 | 500 | 1148 | |
| Metastasis-Incompetent (393P) | #6 | 15.8 | 400 | 28 |
| #7 | 40 | 350 | 112 | |
| #8 | No tumor | 500 | 0 | |
| #9 | No tumor | 600 | 0 |
The metastasis-prone 344SQ or metastasis-incompetent 393P lung cancer cell lines were subcutaneously implanted into mice that were sacrificed 6 weeks after implantation with blood collected for circulating tumor cell quantification